Optogenetic engineered macrophages for light-induced M1 polarization and enhanced chemo-immunotherapy in melanoma models
- 23 September 2025
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 452 (2) , 114770
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82272763)
This publication has 61 references indexed in Scilit:
- Emerging nanomedicines for macrophage-mediated cancer therapyBiomaterials, 2024
- Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapyBiomaterials, 2024
- Engineered CD147-CAR macrophages for enhanced phagocytosis of cancersCancer Immunology, Immunotherapy, 2024
- Astroglial calcium signaling and homeostasis in tuberous sclerosis complexActa Neuropathologica, 2024
- Optogenetic technologies in translational cancer researchBiotechnology Advances, 2022
- GRP78 facilitates M2 macrophage polarization and tumour progressionCellular and Molecular Life Sciences, 2021
- Nanocomplex‐Mediated In Vivo Programming to Chimeric Antigen Receptor‐M1 Macrophages for Cancer TherapyAdvanced Materials, 2021
- Near-infrared light-controlled regulation of intracellular calcium to modulate macrophage polarizationBiomaterials, 2018
- Cot/tpl2 activity is required for TLR‐induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expressionEuropean Journal of Immunology, 2011
- Role of STIM and Orai proteins in the store-operated calcium signaling pathwayCell Calcium, 2007